Browsing Category
Non-Contagious Disease
In an article on ScienceDaily.com, a study, led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC), links the consumption of ultra-processed foods (UPFs) with a higher risk of developing upper aerodigestive tract cancers. Analyzing data from!-->…
Read More...
A new malaria vaccine is being distributed next year to 12 African countries. The vaccine requires multiple doses to be effective and according to scientists, needs to be used with other manual malaria prevention measures, like bed nets.
To read the full article on Wired by Maryn Mckenna, click!-->…
Read More...
Researchers in Copenhagen have found a potential cause of Parkinson's disease in mitochondria. Over time they found that mitochondria experience damage that can lead to damage in mitochondrial DNA and result in the development of Parkinson's and other diseases throughout the brain.
To read the!-->…
Read More...
Sanofi has joined Eli Lilly and Novo Nordisk as the last of the 3 biggest suppliers of insulin in the US to announce price cuts and caps for out-of-pocket costs in insulin. The French drugmaker announced Thursday that it will be capping the out-of-pocket costs of its most popular insulin, Lantus to!-->…
Read More...
At the end of December, the state of California banned flavored tobacco products, including menthol cigarettes. R.J. Reynolds, a cigarette manufacturer that makes Camel and Newport cigarettes, is using round-about language to reach the same target audience of menthol cigarettes, saying that they!-->…
Read More...
On Tuesday, a $590 million provisional settlement was reached with Johnson & Johnson and the country’s three largest medication wholesalers. Hundreds of Native American tribes have experienced abnormally high rates of addiction and mortality amid the opioid crisis. The tribes will be paid a!-->…
Read More...
President Biden plans to establish a “Mission Control” office that would coordinate government agencies to forecast and spot pandemics in the future. The pandemic preparedness plan includes five goals:
1. expand the nation’s arsenal of vaccines, therapeutics, and diagnostics
2. improve!-->…
Read More...
An Alzheimer’s drug manufactured by Eli Lilly has shown to slow down the rate that patients lose their ability to think and care for themselves. This was a small clinical trial with 272 patients and has not yet been published or widely reviewed. However, if the findings are true, then this would be!-->…
Read More...
An important advisory committee in the FDA is set to meet Friday. They will discuss an experimental intravenous treatment for Alzheimer's called aducanumab. If the treatment is well received by the committee it may become the first immunotherapy for Alzheimer’s and the first treatment to show that!-->…
Read More...
Credit: Getty ImagesDuring the current COVID-19 outbreak, the EPA has decided to ease restrictions on pollution. Public health experts are concerned this decision will endanger those who are susceptible to COVID-19 by aggravating respiratory illnesses. Historically, in virus hot spots such as New!-->…
Read More...
Type 2 diabetes affects one in ten Americans adults, which is approximately 30 million people. With this form of diabetes, the body does not produce enough insulin or the cells ignore the insulin present. This causes the blood sugar to be too high. Having Type 2 diabetes increases your risk for!-->…
Read More...
A new study suggests that alcohol has been increasingly responsible for deaths across every race, ethnicity, and gender. These researchers are calling this an “urgent public health crisis.” We know that many diseases such as liver disease and alcohol poisoning are caused by chronic use.!-->…
Read More...
Scientists have found new information about the way in which autism affects communication between neurons in the brain. They found that people with autism have abnormalities in the production of myelin, an insulator for nerve fibers. For more information, click here.
Read More...
The new drug, Palforzia, is a drug approved for use in children between 4-17 years old that minimizes the severity of a child's allergic reaction to peanuts. The treatment works through controlled dosage increases in roughly a six month period. Anaphylaxis can occur at anytime, but especially!-->…
Read More...